Literature DB >> 22023082

Association analyses suggest the effects of RANK and RANKL on age at menarche in Chinese women.

R Pan1, Y-Z Liu, H-W Deng, V Dvornyk.   

Abstract

OBJECTIVES: Age at menarche (AAM), the time of the first menstrual bleeding, is an important developmental milestone in the female life. It marks the beginning of the reproductive period. AAM is implicated in the risk of many health complications in later life. In this study, we conducted an analysis for association of single nucleotide polymorphisms (SNPs) and common haplotypes of two candidate genes, RANK (receptor activator of the NF-κB) and RANKL (receptor activator of the NF-κB ligand), with AAM in 825 unrelated Chinese women.
METHODS: In total, 73 SNPs of RANKL and 23 SNPs of RANK were genotyped. The SNPs and common haplotypes were then analyzed for their association with AAM. Age and age( 2 ) were used as covariates.
RESULTS: We found five individual SNPs (rs7239261, rs8094884, rs3826620, rs8089829, and rs9956850) of RANK significantly associated with AAM (p < 0.05). Although no significant association was identified for the RANKL gene, three polymorphisms showed nearly significant (0.05 < p < 0.08) association with AAM. Seven haplotypes of RANK were significantly associated with AAM (p < 0.05); the most significant association of the AT haplotype composed by rs1805034 and rs4524034 (p = 9.4 × 10(-4)) remained significant (p = 0.0235) after the Bonferroni correction for multiple testing. Three haplotypes of RANKL were significantly associated with AAM (p < 0.05). Importantly, the association of rs3826620 replicated our previous findings for Caucasian females.
CONCLUSIONS: The results of the present study suggest that the RANK and RANKL are two candidate genes for AAM in Chinese women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22023082      PMCID: PMC3682470          DOI: 10.3109/13697137.2011.587556

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  62 in total

1.  Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember?

Authors:  A Must; S M Phillips; E N Naumova; M Blum; S Harris; B Dawson-Hughes; W M Rand
Journal:  Am J Epidemiol       Date:  2002-04-01       Impact factor: 4.897

2.  Polymorphism in the insulin-like growth factor 1 gene is associated with age at menarche in caucasian females.

Authors:  Jian Zhao; Dong-Hai Xiong; Yan Guo; Tie-Lin Yang; Robert R Recker; Hong-Wen Deng
Journal:  Hum Reprod       Date:  2007-03-21       Impact factor: 6.918

3.  The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.

Authors:  J E Fata; Y Y Kong; J Li; T Sasaki; J Irie-Sasaki; R A Moorehead; R Elliott; S Scully; E B Voura; D L Lacey; W J Boyle; R Khokha; J M Penninger
Journal:  Cell       Date:  2000-09-29       Impact factor: 41.582

4.  Family social class, maternal body mass index, childhood body mass index, and age at menarche as predictors of adult obesity.

Authors:  J Laitinen; C Power; M R Järvelin
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

5.  Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples.

Authors:  T Seck; I Diel; H Bismar; R Ziegler; J Pfeilschifter
Journal:  Eur J Endocrinol       Date:  2001-08       Impact factor: 6.664

Review 6.  RANK-L and RANK: T cells, bone loss, and mammalian evolution.

Authors:  Lars E Theill; William J Boyle; Josef M Penninger
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

7.  Reproductive and hormonal factors and ovarian cancer.

Authors:  F Chiaffarino; C Pelucchi; F Parazzini; E Negri; S Franceschi; R Talamini; E Conti; M Montella; C La Vecchia
Journal:  Ann Oncol       Date:  2001-03       Impact factor: 32.976

Review 8.  Update on the etiology, diagnosis and therapeutic management of sexual precocity.

Authors:  Vinicius Nahime Brito; Ana Claudia Latronico; Ivo J P Arnhold; Berenice Bilharinho Mendonça
Journal:  Arq Bras Endocrinol Metabol       Date:  2008-02

Review 9.  Influence of RANKL inhibition on immune system in the treatment of bone diseases.

Authors:  Anne Fouque-Aubert; Roland Chapurlat
Journal:  Joint Bone Spine       Date:  2007-08-29       Impact factor: 4.929

10.  Motif module map reveals enforcement of aging by continual NF-kappaB activity.

Authors:  Adam S Adler; Saurabh Sinha; Tiara L A Kawahara; Jennifer Y Zhang; Eran Segal; Howard Y Chang
Journal:  Genes Dev       Date:  2007-11-30       Impact factor: 11.361

View more
  5 in total

Review 1.  Genetics of pubertal timing.

Authors:  Jia Zhu; Temitope O Kusa; Yee-Ming Chan
Journal:  Curr Opin Pediatr       Date:  2018-08       Impact factor: 2.856

2.  Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women.

Authors:  Peng Duan; Zhi-Ming Wang; Jiang Liu; Li-Na Wang; Zhi Yang; Ping Tu
Journal:  BMC Womens Health       Date:  2015-04-13       Impact factor: 2.809

3.  Genetic polymorphism of the OPG gene associated with breast cancer.

Authors:  Jasmin Teresa Ney; Ingolf Juhasz-Boess; Frank Gruenhage; Stefan Graeber; Rainer Maria Bohle; Michael Pfreundschuh; Erich Franz Solomayer; Gunter Assmann
Journal:  BMC Cancer       Date:  2013-01-31       Impact factor: 4.430

4.  Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment.

Authors:  Joanna Wielińska; Katarzyna Kolossa; Jerzy Świerkot; Marta Dratwa; Milena Iwaszko; Bartosz Bugaj; Barbara Wysoczańska; Monika Chaszczewska-Markowska; Sławomir Jeka; Katarzyna Bogunia-Kubik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2020-08-19       Impact factor: 4.291

5.  The effect of genetic polymorphisms on treatment duration following premolar extraction.

Authors:  Jiyon Yu; Yoon Jeong Choi; Sung-Hwan Choi; Han-Sung Jung; Ji Hyun Lee; Jung-Yul Cha
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.